| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/04/2002 | US20020040003 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus |
| 04/04/2002 | US20020039774 Anticholesterol agents |
| 04/04/2002 | US20020039768 Percyquinnin, a process for its production and its use as a pharmaceutical |
| 04/04/2002 | US20020039736 Reacting aliphatic aminonitrile with water in presence of solid alumina catalyst to form lactam |
| 04/04/2002 | US20020039599 Calibration; administering antiseptic compound |
| 04/04/2002 | US20020039577 Methods for regulating a lymphocyte-mediated immune response by blocking costimulatory signals and blocking LFA-1 mediated adhesion in lymphocytes |
| 04/04/2002 | US20020039574 Delivery of therapeutic gene products by intestinal cell expression |
| 04/04/2002 | US20020039560 Drug delivery |
| 04/04/2002 | DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines) |
| 04/04/2002 | DE10044846A1 Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen Verwendung Agent with a prolonged gastric residence to produce a long-lasting satiation effect and its use |
| 04/04/2002 | DE10044831A1 Verbessertes Verfahren zur mikrobiellen Herstellung von L-Serin sowie ein dazu geeigneter genetisch veränderter Mikroorganismus An improved method for the microbial production of L-serine as well as a thereto suitable genetically modified microorganism |
| 04/04/2002 | DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use |
| 04/04/2002 | DE10043937A1 Production of trivalent chromium complex compound useful for preparing milk product for controlling blood sugar involves addition of lactoferrin or whey protein to a trivalent chromium compound |
| 04/04/2002 | CA2426666A1 Ion-strength independent sustained release pharmaceutical formulation |
| 04/04/2002 | CA2426117A1 Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
| 04/04/2002 | CA2424949A1 Pharmaceutical oxan preparation |
| 04/04/2002 | CA2423978A1 Potassium salt of thiazolidinedione and its use as antidiabetic |
| 04/04/2002 | CA2423975A1 Sodium salts of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 04/04/2002 | CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | CA2423889A1 Methods and compositions for screening modulators of lipid kinases |
| 04/04/2002 | CA2423704A1 G-protein coupled receptors |
| 04/04/2002 | CA2423474A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents |
| 04/04/2002 | CA2423464A1 Hydroxy acid integrin antagonists |
| 04/04/2002 | CA2423434A1 Lactone integrin antagonists |
| 04/04/2002 | CA2423313A1 Methods of treating inflammatory and immune reactions and compositions therefor |
| 04/04/2002 | CA2423305A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | CA2423251A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/04/2002 | CA2423141A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | CA2421620A1 Promoter sequences |
| 04/04/2002 | CA2420851A1 .alpha.-substituted .beta.-aminoethyl phosphonates |
| 04/04/2002 | CA2420475A1 Ige receptor antagonists |
| 04/04/2002 | CA2420045A1 Melanocortin receptor ligands |
| 04/04/2002 | CA2416656A1 Compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/03/2002 | EP1193272A1 Single-chain insulin analogs |
| 04/03/2002 | EP1192951A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 04/03/2002 | EP1192943A2 Use of growth hormone secretagogues in conjunction with physical exercise |
| 04/03/2002 | EP1192938A2 Composition to enhance permeation of topical skin agents |
| 04/03/2002 | EP1192266A2 Complement-resistant non-mammalian dna viruses and uses thereof |
| 04/03/2002 | EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods |
| 04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
| 04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
| 04/03/2002 | EP1192248A1 Antisense modulation of ship-2 expression |
| 04/03/2002 | EP1192165A2 Substituted heterocycle fused gamma-carbolines |
| 04/03/2002 | EP1192158A2 Substituted 8-phenylxanthines useful as antagonists of a 2b? adenosine receptors |
| 04/03/2002 | EP1192148A1 Thiochroman derivatives resisting neurological disorders |
| 04/03/2002 | EP1192144A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids |
| 04/03/2002 | EP1192141A1 1,4-diazacycloheptane derivatives as neuroprotective agents |
| 04/03/2002 | EP1192137A1 COMPOUNDS FOR THE MODULATION OF PPAR$g(g) ACTIVITY |
| 04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
| 04/03/2002 | EP1191931A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 04/03/2002 | EP1007512B1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors |
| 04/03/2002 | EP0809512B1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin |
| 04/03/2002 | CN1343213A 2,3-0-isopropylidene derivatives of monosaccharides as cell adhesive inhibitors |
| 04/03/2002 | CN1343212A Derivatives of monosaccharides as well adhesion inhibitors |
| 04/03/2002 | CN1343208A Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 04/03/2002 | CN1343126A Medicament for treating diabetes |
| 04/03/2002 | CN1343100A Food complement and cosmetic treatment based on grape extract rich in polyphenols |
| 04/03/2002 | CN1342483A Medicine for treating diabetes and its preparing process |
| 04/03/2002 | CN1342464A Antivirus antioxidizing active extract of proplis and its molecular inclusion compound |
| 04/03/2002 | CN1342461A Process for preparing embryo nutrient |
| 04/03/2002 | CN1342456A Process for preparing medicine to prevent and cure diabetes, hyperlipomia and obesity |
| 04/02/2002 | US6365796 Transgenic UCP2 knockout mouse and use thereof |
| 04/02/2002 | US6365768 Interleukin-1 and tumor necrosis factors-α modulators, syntheses of said modulators and methods of using modulators |
| 04/02/2002 | US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 04/02/2002 | US6365736 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 04/02/2002 | US6365633 Method of treating eating disorders |
| 04/02/2002 | US6365628 Fatty analogues for the treatment of diabetes |
| 04/02/2002 | US6365622 Antioxidant composition comprising acetyl L-carnitine and α-lipoic acid |
| 04/02/2002 | US6365616 Transplant rejection |
| 04/02/2002 | US6365609 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 04/02/2002 | US6365607 Thiazolidinedione and oxazolidinedione compounds for treatment of diabetic anemia, edema, and anorexia |
| 04/02/2002 | US6365598 Pyrroloquinolines for treatment of obesity |
| 04/02/2002 | US6365572 For therapy of diseases related to increased or unwanted synthesis of basement membranes such as diabetes mellitus; atherosclerosis; cancer; diabetic retinopathia; fibroplasia retrolentalis; or psoriasis, rheumatoic arthritis |
| 04/02/2002 | US6365370 Dna which codes for 5-hydroxytryptamine 3-c protein of defined amino acid sequence; antiinflammatory agents; treatment of huntington's disease, alzheimer's disease and others |
| 04/02/2002 | US6365186 Combination therapy for treating hypercholesterolemia |
| 04/02/2002 | US6365177 Insulin supplemented infant formula |
| 04/02/2002 | US6365176 Nutritional supplement comprising low-glycemic index carbohydrate source, source of protein, source of fat, source of sterol and/or stanol, source of chromium, source of salicylic acid, and source of ginseng |
| 04/02/2002 | US6365154 Tie2 agonist antibodies |
| 04/02/2002 | CA2357925A1 Prophylactic use of n-methyl-d-asparate (nmda) antagonists |
| 04/02/2002 | CA2101273C Arachidonic acid and methods for the production and use thereof |
| 04/02/2002 | CA2051012C Carbocyclic adenosine analogs useful as immunosupressants |
| 04/02/2002 | CA2039909C Substituted 3-thia- and 3-oxa-alkylflavones, a process for their preparation, the use thereof, medicaments based on these compounds and intermediates |
| 03/29/2002 | CA2357998A1 Composition to enhance permeation of topical skin agents |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024754A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 03/28/2002 | WO2002024727A2 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | WO2002024715A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 03/28/2002 | WO2002024711A1 Novel thiazole bicyclic compounds |
| 03/28/2002 | WO2002024702A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/28/2002 | WO2002024701A2 Substituted azepino[4,5b)indole derivatives |
| 03/28/2002 | WO2002024700A2 SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES |
| 03/28/2002 | WO2002024698A1 Xanthine phosphodiesterase v inhibitors |
| 03/28/2002 | WO2002024694A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics |
| 03/28/2002 | WO2002024689A1 Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis |
| 03/28/2002 | WO2002024683A1 Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024672A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/28/2002 | WO2002024662A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 03/28/2002 | WO2002024659A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists |
| 03/28/2002 | WO2002024658A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |